| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 12/30/2003 | US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 12/30/2003 | US6670327 bactericidal/ permeability-increasing protein (BPI) protein |
| 12/30/2003 | US6670321 Prevention and treatment for retinal ischemia and edema |
| 12/30/2003 | US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders |
| 12/30/2003 | US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties |
| 12/30/2003 | US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes |
| 12/30/2003 | CA2102241C Use of macrolide compounds for eye diseases |
| 12/30/2003 | CA2099970C Composition for curing sjoegren syndrome disease |
| 12/25/2003 | WO2003105846A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
| 12/25/2003 | US20030236389 Proteins, polynucleotides encoding them and methods of using the same |
| 12/25/2003 | US20030236307 Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders |
| 12/25/2003 | US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders |
| 12/25/2003 | US20030236281 Quinoline derivatives(2) |
| 12/25/2003 | US20030236273 Aryl substituted pyrimidines and the use thereof |
| 12/25/2003 | US20030236270 Central nervous system disorders |
| 12/25/2003 | US20030236264 Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease |
| 12/25/2003 | US20030236263 Chemical compounds |
| 12/25/2003 | US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 12/25/2003 | US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease |
| 12/25/2003 | US20030236238 Respiratory system disorders; asthma; stable powder form of formoterol; storage stability |
| 12/25/2003 | US20030236182 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 12/25/2003 | US20030235880 Genetic engineered nucleic acid |
| 12/25/2003 | US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof |
| 12/25/2003 | US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha |
| 12/25/2003 | US20030235584 Method for preparing anti-MIF antibodies |
| 12/24/2003 | WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | WO2003106506A1 Low molecular weight oversulfated polysaccharide |
| 12/24/2003 | WO2003106505A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 12/24/2003 | WO2003106504A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 12/24/2003 | WO2003106462A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 12/24/2003 | WO2003106416A2 Chemical process |
| 12/24/2003 | WO2003106401A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/24/2003 | WO2003105872A1 Anti-spasmodic comprising xenon |
| 12/24/2003 | WO2003105868A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | WO2003105867A1 Quaternised ammonium cyclodextrin compounds |
| 12/24/2003 | WO2003105856A1 Combination of azelastine and steroids |
| 12/24/2003 | WO2003105847A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105831A1 Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders |
| 12/24/2003 | WO2003105816A1 Method of treating rosacea by topical application of a cyclohexane derivative |
| 12/24/2003 | WO2003105800A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | WO2003105781A2 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105776A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 12/24/2003 | WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | WO2003105724A2 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | WO2003090662A3 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
| 12/24/2003 | WO2003089007B1 Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu |
| 12/24/2003 | WO2003086396A9 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 12/24/2003 | WO2003082807A3 Amino acids with affinity for the alpha-2-delta-protein |
| 12/24/2003 | WO2003082257A3 Method for treating ocular hypertension and glaucoma |
| 12/24/2003 | WO2003076414A3 Aryl substituted pyrimidines and the use thereof |
| 12/24/2003 | WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/24/2003 | WO2003070182A3 Sodium channel blockers |
| 12/24/2003 | WO2003068166A3 Treatment of ophthalmic disorders using urea and urea derivatives |
| 12/24/2003 | WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene |
| 12/24/2003 | WO2003063826A3 Ophthalmic compositions including oil-in-water emulsions, and methods for making and using the same |
| 12/24/2003 | WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 12/24/2003 | WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE |
| 12/24/2003 | WO2003038095A3 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents |
| 12/24/2003 | WO2003028701A3 Liposomes containing (ether)lysolecithins |
| 12/24/2003 | WO2003006491A3 Peptide-based compounds for targeting intergin receptors |
| 12/24/2003 | WO2002100858A8 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 12/24/2003 | WO2002094177A3 Novel nucleic acids and their therapeutic use in ophthalmology |
| 12/24/2003 | WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 12/24/2003 | WO2001052878A8 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 12/24/2003 | CN1462621A Formula of liquid for moist of eyes and its preparation method |
| 12/24/2003 | CN1131868C 作为药物的三环△3－哌啶 As a tricyclic drug △ 3- piperidine |
| 12/24/2003 | CA2779633A1 Combination of azelastine and steroids |
| 12/24/2003 | CA2779630A1 Combination of azelastine and steroids |
| 12/24/2003 | CA2489870A1 Low molecular weight oversulfated polysaccharide |
| 12/24/2003 | CA2489866A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 12/24/2003 | CA2489648A1 Chemical process |
| 12/24/2003 | CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/24/2003 | CA2489106A1 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | CA2488884A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension |
| 12/24/2003 | CA2488802A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | CA2488752A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 12/23/2003 | US6667393 Azalide antibiotic compositions |
| 12/23/2003 | US6667300 Purinyl substituted quinazoline-4-one derivatives |
| 12/23/2003 | CA2302232C Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent |
| 12/18/2003 | WO2003104407A2 T cell receptor cdr3 sequences and methods for detection |
| 12/18/2003 | WO2003104268A1 Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 12/18/2003 | WO2003104260A2 Pharmaceutical formulation |
| 12/18/2003 | WO2003104230A1 Bicyclic pyrimidine derivatives |
| 12/18/2003 | WO2003104226A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/18/2003 | WO2003104225A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/18/2003 | WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors |
| 12/18/2003 | WO2003104222A1 Bisindolyl-maleimid derivatives as kinase inhibitors |
| 12/18/2003 | WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 12/18/2003 | WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 12/18/2003 | WO2003104205A1 Aryloximes |
| 12/18/2003 | WO2003104204A1 Pyridazine derivatives |
| 12/18/2003 | WO2003104203A1 Therapeutic molecules and methods-1 |
| 12/18/2003 | WO2003104198A1 Chemokine receptor antagonist |